Table 4

Operative characteristics in the current study (UK AVR) and those in other national registries and recent trials comparing SAVR with TAVI

CharacteristicUK SAVRThourani
et al15
Tokuda
et al16
Partner 2A22Partner 36Evolut7PIVOTAL5NOTION18
SAVR N=31 277SAVR
N=141 905
SAVR
N=20 514
SAVR
N=1021
TAVI
N=1011
SAVR
N=454
TAVI
N=496
SAVR
N=678
TAVI
N=725
SAVR
N=357
TAVI
N=390
SAVR
N=135
TAVI
N=145
Operative urgency
Elective (%)74.3NRNRNRNRNRNRNRNRNRNRNRNR
Urgent (%)24NRNRNRNRNRNRNRNRNRNRNRNR
Emergency/salvage (%)1.7NRNRNRNRNRNRNRNRNRNRNRNR
Concomitant CABG (%)37.1NRNRNR12.813.64.81
Staged PCINRNRNR6.56.90.3%0
Cross clamp time (minutes)79.077.0±28.5NRNR74.3±27.7868.7±29.074.0±31.4NRNR
Cardiopulmonary bypass time (minutes)104104.9±39.1NRNR97.7±33.7593.4±40.2104.0±45.8NRNR
Procedure time (minutes)NRNRNRNRNR208.3±62.158.6±36.5276.6±79.5148.2±55.1221±84.860.4±35.3177.2±39.890.3±38.6
  • AVR, aortic valve replacement; CABG, coronary artery bypass graft surgery; NR, not reported; PCI, percutaneous coronary interverntion; SAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation.